CHIMOVITS EREZ purchased 0.7% of their position (61.52K shares) of ADARX PHARMACEUTICALS, INC. on the open market

Open‑market purchase worth $1.05M — a small addition. The strongest form of insider conviction signal.

P · 1 purchase

CHIMOVITS EREZ

Filed: 9/30/2026ACC: 0000947871-26-000912

InsiderCHIMOVITS EREZCIK 1706399

→

IssuerADARX PHARMACEUTICALS, INC.CIK 1802369

Director

Since Sep 2026

+61.52K

Net shares

Net buyer

$1.05M

Total acquired

Open market trades

1B · 0S

Total transactions

9.29M acquired · 9.23M disposed

Non-Derivative Transactions5

Common Stock

Indirect

C · Conversion

+7.13M

Price / share

—

Trade value

—

% of position

New position

9/28/2026

0.00→7.13M

Common Stock

Indirect

C · Conversion

+1.33M

Price / share

—

Trade value

—

% of position

18.7%

9/28/2026

7.13M→8.46M

Common Stock

Indirect

C · Conversion

+513.07K

Price / share

—

Trade value

—

% of position

6.1%

9/28/2026

8.46M→8.97M

Common Stock

Indirect

C · Conversion

+256.45K

Price / share

—

Trade value

—

% of position

2.9%

9/28/2026

8.97M→9.23M

Common Stock

Indirect

P · Purchase

+61.52K

Price / share

$17.00

Trade value

$1.05M

% of position

0.7%

9/28/2026

9.23M→9.29M

Total

Net shares

+9.29M

Net value

$1.05M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Indirect	9/28/2026	C · Conversion	+7.13M	—	—	New position	0.00	7.13M
Common Stock Indirect	9/28/2026	C · Conversion	+1.33M	—	—	18.7%	7.13M	8.46M
Common Stock Indirect	9/28/2026	C · Conversion	+513.07K	—	—	6.1%	8.46M	8.97M
Common Stock Indirect	9/28/2026	C · Conversion	+256.45K	—	—	2.9%	8.97M	9.23M
Common Stock Indirect	9/28/2026	P · Purchase	+61.52K	$17.00	$1.05M	0.7%	9.23M	9.29M
Total			+9.29M		$1.05M

Derivative Transactions4

Series A Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

7.13M shares

−7.13M

Strike price

Held after

0.00

Exercisable

—

9/28/2026

Series B Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

1.33M shares

−1.33M

Strike price

Held after

0.00

Exercisable

—

9/28/2026

Series B-1 Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

513.07K shares

−513.07K

Strike price

Held after

0.00

Exercisable

—

9/28/2026

Series C Preferred Stock

Indirect

C · Conversion

Converts to

Common Stock

256.45K shares

−256.45K

Strike price

Held after

0.00

Exercisable

—

9/28/2026

Security	Converts To	Date	Type	Shares	Exercisable
Series A Preferred Stock Indirect	Common Stock7.13M shares	9/28/2026	C · Conversion	−7.13M	—
Series B Preferred Stock Indirect	Common Stock1.33M shares	9/28/2026	C · Conversion	−1.33M	—
Series B-1 Preferred Stock Indirect	Common Stock513.07K shares	9/28/2026	C · Conversion	−513.07K	—
Series C Preferred Stock Indirect	Common Stock256.45K shares	9/28/2026	C · Conversion	−256.45K	—